BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24703046)

  • 21. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
    Selvin E; Warren B; He X; Sacks DB; Saenger AK
    Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
    Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan.
    Hsu P; Ai M; Kanda E; Yu NC; Chen HL; Chen HW; Cheng MH; Kohzuma T; Schaefer EJ; Yoshida M
    Atherosclerosis; 2015 Sep; 242(1):327-33. PubMed ID: 26247684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
    Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
    J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus.
    Shima K; Abe F; Chikakiyo H; Ito N
    Diabetes Res Clin Pract; 1989 Nov; 7(4):243-50. PubMed ID: 2612342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
    Juraschek SP; Steffes MW; Selvin E
    Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated albumin and diabetes mellitus.
    Furusyo N; Hayashi J
    Biochim Biophys Acta; 2013 Dec; 1830(12):5509-14. PubMed ID: 23673238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycated Albumin and Risk of Mortality in the US Adult Population.
    Rooney MR; Daya N; Tang O; McEvoy JW; Coresh J; Christenson RH; Selvin E
    Clin Chem; 2022 Mar; 68(3):422-430. PubMed ID: 35092265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Among Glycemic Biomarkers in Korean Adults: Hemoglobin A1c, Fructosamine, and Glycated Albumin.
    Choi R; Park MJ; Lee S; Lee SG; Lee EH
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study.
    Rawlings AM; Sharrett AR; Albert MS; Coresh J; Windham BG; Power MC; Knopman DS; Walker K; Burgard S; Mosley TH; Gottesman RF; Selvin E
    Diabetes Care; 2019 Jul; 42(7):1248-1254. PubMed ID: 31221696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.
    Shafi T; Sozio SM; Plantinga LC; Jaar BG; Kim ET; Parekh RS; Steffes MW; Powe NR; Coresh J; Selvin E
    Diabetes Care; 2013 Jun; 36(6):1522-33. PubMed ID: 23250799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
    Danese E; Montagnana M; Nouvenne A; Lippi G
    J Diabetes Sci Technol; 2015 Mar; 9(2):169-76. PubMed ID: 25591856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A
    Hobabagabo AF; Osei-Tutu NH; Hormenu T; Shoup EM; DuBose CW; Mabundo LS; Ha J; Sherman A; Chung ST; Sacks DB; Sumner AE
    Diabetes Care; 2020 Oct; 43(10):2607-2613. PubMed ID: 32801129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of glycated albumin in postmortem blood samples as the diagnostic parameters of diabetes mellitus.
    Akane A; Shiono H; Matsubara K; Tanabe K; Nakamura H; Hasegawa M; Kagawa M
    Nihon Hoigaku Zasshi; 1992 Aug; 46(4):237-43. PubMed ID: 1405016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycated albumin and HbA1c as markers of lower extremity disease inUS adults with and without diabetes.
    Hicks CW; Wang D; Matsushita K; McEvoy JW; Christenson R; Selvin E
    Diabetes Res Clin Pract; 2022 Feb; 184():109212. PubMed ID: 35066057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.